Appeal No. 1997-2167 Application 08/137,444 THE INVENTION The appealed subject matter is directed to a genus of compounds which may be broadly characterized as galanthamine derivatives, pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an acetylcholinesterase (AChE) inhibiting amount of the galanthamine derivative, methods of treating memory dysfunction characterized by decreased cholinergic function by administering to a mammal an AChE inhibiting amount of the galanthamine derivative and methods of treating memory dysfunction characterized by decreased cholingeric function by administering to a mammal an AChE inhibiting amount of the galanthamine derivative which metabolizes in situ to form 6-O- demethylgalanthamine. According to appellants, the claimed family of galanthamine derivatives possesses the ability to inhibit the enzyme AchE. The enzyme AChE lowers acetylcholine levels in the brain. Inhibition of AChE therefore increases brain levels of acetylcholine. Claims 1, 2, 48, 49 and 50 are believed to be adequately representative of the appealed subject matter and are reproduced below for a more facile understanding of 2Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007